Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,861.84
(
-0.04%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
95.05
(
4.82%
)
Bitcoin
75,556.98
(
-0.44%
)
News Focus
News Focus
Post# of 80490
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

micanwait

Send PM Follow Ignore
Followers 6
Posts 718
Boards Moderated 0
Alias Born 06/22/2011

micanwait

Re: Whosetosay post# 74200

Sunday, 06/26/2016 7:44:01 AM

Sunday, June 26, 2016 7:44:01 AM

Post# of 80490
"Then, Ariad is a much simpler, higher valuation as a primarily lung cancer biotech with a very promising drug coming on market, going 1st line, with a solid pipeline behind it."

This seems so obvious to me. It begs the question... is Denner just dumb (doubtful) or is there some conflict of interest here regarding the performance of his fund?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today